Press releases

2019/07/03 6:00PM
|

Quantum Genomics Selected to Enter the European Rising Tech Label

2019/06/27 6:00PM
|

Quantum Genomics Announces Result of Annual General Meeting

2019/06/12 6:00PM
|

A key milestone reached by Quantum Genomics in the development of firibastat

2019/06/06 6:00PM
|

Quantum Genomics Enrolls First Patient in QUORUM Phase IIb Study of Firibastat in Heart Failure Patients

2019/05/10 12:00AM
|

Quantum Genomics Announces the Publication of a New Scientific Article in the Journal Hypertension

2019/04/26 2:00PM
|

Quantum Genomics Announces the Publication of its Phase IIb NEW-HOPE Study Results of Firibastat in Arterial Hypertension in the Journal Circulation

2019/04/17 6:00PM
|

Quantum Genomics Receives First Regulatory and Ethics Approvals to Initiate Phase IIb QUORUM Study of Firibastat in Heart Failure

2019/03/28 6:00PM
|

Quantum Genomics Reports Full-Year 2018 Financial Results

2019/03/20 6:00PM
|

Quantum Genomics Announces Positive Results from New Preclinical Studies on Firibastat

2019/02/25 6:00PM
|

Quantum Genomics Completes Enrollment in Its Pharmacokinetic Clinical Study of Firibastat

2019/02/06 6:00PM
|

Quantum Genomics Announces the Publication of Two Scientific Articles Confirming the Efficacy of Firibastat for Heart Failure

2019/01/31 6:45PM
|

Quantum Genomics Presents its 2019 Corporate Action Plan

2019/01/23 6:00PM
|

The Association of Black Cardiologists and the Heart Institute of the Caribbean Conclude Successful First Annual Joint "Masters of Cardiology" Conference in Kingston, Jamaica

2019/01/17 6:00PM
|

Quantum Genomics Appoints Steering Committee for its Phase III Pivotal Trial in Resistant Hypertension